Danaher Corporation (LON:0R2B)
210.87
-0.46 (-0.22%)
At close: Nov 6, 2025
Danaher Market Cap
Danaher has a market cap or net worth of 112.63 billion as of November 7, 2025. Its market cap has decreased by -21.17% in one year.
Market Cap
112.63B
Enterprise Value
125.27B
Revenue
18.10B
Ranking
n/a
PE Ratio
43.12
Stock Price
210.87
Market Cap Chart
Since December 10, 1969, Danaher's market cap has increased from 207.76M to 112.63B, an increase of 54,111.18%. That is a compound annual growth rate of 11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 112.63B | -14.95% |
| Dec 31, 2024 | 132.43B | -1.32% |
| Dec 29, 2023 | 134.20B | -16.31% |
| Dec 30, 2022 | 160.36B | -7.64% |
| Dec 31, 2021 | 173.63B | 50.22% |
| Dec 31, 2020 | 115.58B | 38.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 71.07B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |